Cargando…

Lopinavir-Ritonavir Associated Acute Kidney Injury Is Not Related to Crystalluria in Critically Ill COVID-19 Patients

Detalles Bibliográficos
Autores principales:	Arrestier, Romain, Stehle, Thomas, Letavernier, Emmanuel, Mekontso-Dessap, Armand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448877/ https://www.ncbi.nlm.nih.gov/pubmed/32869007 http://dx.doi.org/10.1016/j.ekir.2020.08.021

Ejemplares similares

Prevalence and identification of crystalluria in critically ill patients: association between uric acid crystals and sepsis
por: Tabibzadeh, Nahid, et al.
Publicado: (2020)

Acute Kidney Injury in Critically-Ill COVID-19 Patients
por: Arrestier, Romain, et al.
Publicado: (2022)

Description of Stone Morphology and Crystalluria Improve Diagnosis and Care of Kidney Stone Formers
por: Letavernier, Emmanuel, et al.
Publicado: (2022)

Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19
por: Razazi, Keyvan, et al.
Publicado: (2021)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

The administration of lopinavir/ritonavir via an enteral feeding tube()
por: Sirvent Segovia, Alejandro Esteban, et al.
Publicado: (2021)

Serum cytokines profile of critically ill COVID-19 patients with cardiac dysfunction
por: Bagate, François, et al.
Publicado: (2021)

Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19
por: Binois, Yannick, et al.
Publicado: (2020)

Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
por: Mazan, Paula, et al.
Publicado: (2020)

Reply to: Gaudry et al.
por: Mekontso Dessap, Armand, et al.
Publicado: (2023)

A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
por: Joumaa, H., et al.
Publicado: (2020)

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results
por: Ader, Florence
Publicado: (2022)

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
por: Klement-Frutos, Elise, et al.
Publicado: (2021)

Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir()
por: Gimeno Castillo, Javier, et al.
Publicado: (2021)

Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
por: Cattaneo, Dario, et al.
Publicado: (2020)

Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
por: Schneider, Johanna, et al.
Publicado: (2021)

SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients
por: Fourati, Slim, et al.
Publicado: (2020)

Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study
por: Lora-Tamayo, Jaime, et al.
Publicado: (2021)

Azithromycin/lopinavir/ritonavir: Acute kidney injury following off label use: case report
Publicado: (2021)

Lopinavir/ritonavir: Acute kidney injury following off-label use: 8 case reports
Publicado: (2020)

Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”
por: Simon, Nicolas, et al.
Publicado: (2020)

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
por: Hraiech, Sami, et al.
Publicado: (2020)

Phosphonoformate Crystalluria, A Warning Signal of Foscarnet-Induced Kidney Injury
por: Deffert, Christine, et al.
Publicado: (2020)

Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010)

Lopinavir-Ritonavir-Kombination nicht wirksam
por: Diener, Hans-Christoph
Publicado: (2020)

Chest computed tomography characteristics of critically ill COVID-19 patients with auto-antibodies against type I interferons
por: Rapnouil, Baptiste Lafont, et al.
Publicado: (2023)

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2021)

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023)

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b
por: Hong, Sun In, et al.
Publicado: (2020)

Is the efficacy of remdesivir so different from that of lopinavir–ritonavir in severe COVID-19? The answer by real time-PCR: a narrative review
por: Duarte, Tiago Isidoro, et al.
Publicado: (2021)

Propofol/lopinavir/ritonavir: Bradyarrythmia: case report
Publicado: (2020)

Potential protective effects of continuous anterior chest compression in the acute respiratory distress syndrome: physiology of an illustrative case
por: Carteaux, Guillaume, et al.
Publicado: (2021)

Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2013)

Administración de lopinavir/ritonavir a través de sonda de nutrición enteral
por: Sirvent Segovia, Alejandro Esteban, et al.
Publicado: (2021)

Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
por: Masi, Paul, et al.
Publicado: (2020)

Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Modulations of human placental transfer of lopinavir, ritonavir and enfuvirtide
por: Ceccaldi, Pierre-François, et al.
Publicado: (2010)

Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
por: Alvarez, Jean Claude, et al.
Publicado: (2020)

Lopinavir/ritonavir: vomiting and watery diarrhoea: case report
Publicado: (2020)

Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8f88o0hihsg7ktmqatmec4n2sd